Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -0.99% | 60.98 | 0.0% | $944.37m | |
| GILD | Gilead Sciences, Inc. | 0.61% | 76.52 | 1.0% | $773.37m | |
| AMGN | Amgen, Inc. | 8.17% | 255.12 | 1.3% | $748.85m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -2.32% | 609.17 | 2.5% | $678.56m | |
| NVAX | Novavax, Inc. | -1.51% | 78.50 | 102.0% | $597.80m | |
| BIIB | Biogen, Inc. | -1.04% | 264.77 | 1.6% | $543.38m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -1.39% | 286.28 | 1.9% | $524.18m | |
| ILMN | Illumina, Inc. | -0.49% | 368.55 | 3.5% | $308.59m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.13% | 112.39 | 2.0% | $229.11m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 2.03% | 125.84 | 4.3% | $214.73m | |
| SGEN | Seattle Genetics, Inc. | -1.41% | 167.52 | 6.1% | $201.85m | |
| SRNE | Sorrento Therapeutics, Inc. | 5.34% | 7.30 | 1.8% | $196.91m | |
| SRPT | Sarepta Therapeutics, Inc. | 3.33% | 165.68 | 13.9% | $168.66m | |
| INCY | Incyte Corp. | 0.01% | 102.66 | 2.5% | $160.01m | |
| IMMU | Immunomedics, Inc. | 4.15% | 36.91 | 11.0% | $154.32m |
Company Profile
Solid Biosciences, Inc. engages in the development of treatments for patients with Duchenne muscular dystrophy. It develops gene therapies, disease modifying therapies, and assistive devices for the cure of DMD. The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Arnold, Annie Ganot and Gilad David Hayeem in March 2013 and is headquartered in Cambridge, MA.